Chordoma treatment at Anadolu Medical Center

Chordoma treatment at Anadolu Medical Center in Gebze, Turkey, provides a complete care pathway. Consultations with an oncologist may cost around $170, while advanced imaging like a PET-CT is around $1,056. Radiation therapy is a core treatment, with full courses typically costing around $16,000. The clinic operates under Johns Hopkins affiliation, following American standards with a specialized multidisciplinary team.

Diagnostic Services for Chordoma

Accurate diagnosis guides the treatment plan. The clinic offers a full range of tests. These are performed by experienced specialists. The available diagnostic options include:

• Oncologist consultation for initial assessment.
• Advanced imaging like MRI (around $650), CT scan (around $750), and PET CT scan (around $1,056).
• Genetic screening, which may cost between $1,000 and $2,500.
• Pathology consultation on tissue samples.

Advanced Treatment Options

The neurosurgery department, led by Prof. Serdar Kahraman, specializes in chordoma. The clinic offers several non-surgical and medical therapies. Each plan is created by the multidisciplinary team.

Available treatments include:

• CyberKnife radiosurgery: This is a precise, outpatient procedure. It targets the tumor with high accuracy. It avoids damage to surrounding healthy tissue.
• Radiation therapy: This includes intensity-modulated techniques. It is effective for residual or recurrent tumors. Hospital stay is minimal, often just 1-2 nights per session.
• Pembrolizumab therapy: This is an immunotherapy option. It involves infusions every three weeks. It is an alternative for cases not suitable for surgery or radiation.
• Tyrosine kinase inhibitors (TKI): These are oral targeted drugs. They are taken daily. They offer a non-surgical option for advanced disease.

All therapies are supported by systemic therapy assessment and surveillance. The clinic provides a free second medical opinion for complex cases. It also offers practical support like interpreter services.